» Authors » Boris Rudic

Boris Rudic

Explore the profile of Boris Rudic including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 75
Citations 764
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Xie J, Bicu A, Grehn M, Kuru M, Zaman A, Lu X, et al.
Phys Imaging Radiat Oncol . 2025 Feb; 33:100700. PMID: 39911878
Background And Purpose: Motion management strategies such as gating under breath-hold can reduce breathing-induced motion during stereotactic arrhythmia radioablation (STAR) for refractory ventricular tachycardia. However, heartbeat-induced motion is essential to...
2.
Rudic B, Kauferstein S, Akin I, Borggrefe M
HeartRhythm Case Rep . 2024 Dec; 10(10):699-701. PMID: 39664848
No abstract available.
3.
Hohmann S, Xie J, Eckl M, Grehn M, Karfoul N, Janorschke C, et al.
Radiother Oncol . 2024 Sep; 200:110499. PMID: 39242029
Background: Stereotactic arrhythmia radioablation (STAR) is a therapeutic option for ventricular tachycardia (VT) where catheter-based ablation is not feasible or has previously failed. Target definition and its transfer from electro-anatomic...
4.
Kuschyk J, Sattler K, Fastenrath F, Rudic B, Akin I
Herz . 2024 May; 49(3):233-246. PMID: 38709278
Cardiac device therapy provides not only treatment options for bradyarrhythmia but also advanced treatment for heart failure and preventive measures against sudden cardiac death. In heart failure treatment it enables...
5.
Lamba A, Roston T, Peltenburg P, Kallas D, Franciosi S, Lieve K, et al.
Heart Rhythm . 2024 Apr; 21(10):1767-1776. PMID: 38588993
Background: Catecholaminergic polymorphic ventricular tachycardia (CPVT) may cause sudden cardiac death (SCD) despite medical therapy. Therefore, implantable cardioverter-defibrillators (ICDs) are commonly advised. However, there is limited data on the outcomes...
6.
Rudic B, Borggrefe M
Herzschrittmacherther Elektrophysiol . 2024 Mar; 35(Suppl 1):118-126. PMID: 38427036
In 1930, Wolff, Parkinson and White described the syndrome that bears their names. The mechanisms of supraventricular tachycardias were analyzed by brilliant electrocardiography interpretation by Pick and Langendorf. Wellens and...
7.
Yuecel G, Stoesslein K, Gaasch L, Kodeih A, Oeztuerk O, Hetjens S, et al.
Acta Cardiol . 2023 Nov; 79(3):327-337. PMID: 37961770
Background: Cardiac resynchronisation therapy (CRT) can be necessary in patients with chronic heart failure, who have already been provided with transvenous cardiac implantable electrical devices. Upgrade procedures revealed controversial results,...
8.
Schrickel J, Beiert T, Linhart M, Luetkens J, Schmitz J, Schmid M, et al.
Clin Res Cardiol . 2023 Nov; 113(8):1183-1199. PMID: 37921923
Background And Objectives: Long-term oral anticoagulation (OAC) following successful catheter ablation of atrial fibrillation (AF) remains controversial. Prospective data are missing. The ODIn-AF study aimed to evaluate the effect of...
9.
van der Ree M, Hoeksema W, Luca A, Visser J, Balgobind B, Zumbrink M, et al.
Radiother Oncol . 2023 Sep; 189:109910. PMID: 37709052
Background: Stereotactic arrhythmia radioablation (STAR) appears to be beneficial in selected patients with therapy-refractory ventricular tachycardia (VT). However, high-dose radiotherapy used for STAR-treatment may affect functioning of the patients' implantable...
10.
Kaestner L, Boda-Heggemann J, Fanslau H, Xie J, Schweikard A, Giordano F, et al.
Strahlenther Onkol . 2023 Sep; 199(11):1018-1024. PMID: 37698592
Background: Electroanatomical mapping (EAM)-guided stereotactic arrhythmia radioablation (STAR) is a novel noninvasive therapy option for patients with monomorphic ventricular tachycardia (VT) refractory to antiarrhythmic drugs and/or urgent catheter ablation (CA)....